222 related articles for article (PubMed ID: 29985715)
1. The Prevention and Therapy of Osteoporosis: A Review on Emerging Trends from Hormonal Therapy to Synthetic Drugs to Plant-Based Bioactives.
Gupta T; Das N; Imran S
J Diet Suppl; 2019; 16(6):699-713. PubMed ID: 29985715
[TBL] [Abstract][Full Text] [Related]
2. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
[TBL] [Abstract][Full Text] [Related]
3. [The necessity of cost-effectiveness analysis in osteoporosis].
Lamy O; Krieg MA
Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
[TBL] [Abstract][Full Text] [Related]
4. [Current views on the interaction between the treatment of osteoporosis and cardiovascular diseases].
Zapolski T; Wysokiński A
Wiad Lek; 2016; 69(4):665-674. PubMed ID: 27941208
[TBL] [Abstract][Full Text] [Related]
5. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
Lewiecki EM
J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis prevention and therapy: preserving and building strength through bone quality.
Kleerekoper M
Osteoporos Int; 2006 Dec; 17(12):1707-15. PubMed ID: 16909196
[TBL] [Abstract][Full Text] [Related]
8. A comparison between bisphosphonates and other treatments for osteoporosis.
Le Goff B; Guillot P; Glémarec J; Berthelot JM; Maugars Y
Curr Pharm Des; 2010; 16(27):3037-44. PubMed ID: 20722614
[TBL] [Abstract][Full Text] [Related]
9. [Up-to-date treatments for osteoporosis].
Bors K
Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
[TBL] [Abstract][Full Text] [Related]
10. An overview on the treatment of postmenopausal osteoporosis.
Maeda SS; Lazaretti-Castro M
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):162-71. PubMed ID: 24830593
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
12. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological agents and natural compounds: available treatments for osteoporosis.
Martiniakova M; Babikova M; Omelka R
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of plant sources on the treatment of osteoporosis.
Süntar I; Akkol EK
Curr Drug Targets; 2013 Dec; 14(13):1611-8. PubMed ID: 23978060
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
Kastelan D; Giljevic Z; Kraljevic I; Korsic M
Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
[TBL] [Abstract][Full Text] [Related]
16. Safety concerns with the long-term management of osteoporosis.
Reginster JY; Pelousse F; Bruyère O
Expert Opin Drug Saf; 2013 Jul; 12(4):507-22. PubMed ID: 23614635
[TBL] [Abstract][Full Text] [Related]
17. [Anti-osteoporosis drugs : their characteristics and evidence for anti-fracture efficacy].
Takeuchi Y
Clin Calcium; 2012 Jun; 22(6):897-903. PubMed ID: 22653031
[TBL] [Abstract][Full Text] [Related]
18. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
Gallacher SJ; Dixon T
Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
20. [Present development of new drugs for osteoporosis].
Wada S
Clin Calcium; 2006 Jan; 16(1):176-81. PubMed ID: 16397369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
